Holen Sie sich die Stockscreener-App
4.22
10.40%
-0.49
Handel nachbörslich:
4.22
Molecular Partners Ag Adr Aktie (MOLN) Neueste Nachrichten
Molecular Partners Reports Highlights and Financial Results for Full Year 2025 - GlobeNewswire Inc.
Will Petrobras Pull Off Q4 Earnings Beat on Strong Production? - Nasdaq
Molecular Partners (MOLN) to Release Quarterly Earnings on Thursday - Defense World
Molecular Partners (NASDAQ:MOLN) Stock Price Down 1.5%Should You Sell? - MarketBeat
Molecular Partners Highlights Favorable MP0712 DLL3 Radiotherapeutic Imaging, U.S. Phase I/II Ready - Yahoo Finance
Research Analysts Offer Predictions for MOLN FY2025 Earnings - Defense World
Brokers Offer Predictions for MOLN FY2025 Earnings - MarketBeat
What is HC Wainwright's Estimate for MOLN Q1 Earnings? - MarketBeat
Molecular Partners stock initiated with Buy rating at H.C. Wainwright By Investing.com - Investing.com India
Molecular Partners stock initiated with Buy rating at H.C. Wainwright - Investing.com
Molecular Partners AG Sponsored ADR (NASDAQ:MOLN) Short Interest Down 17.9% in December - MarketBeat
Analysts Offer Insights on Healthcare Companies: Sanofi (OtherSNYNF) and Abivax SA Sponsored ADR (ABVX) - The Globe and Mail
Molecular Partners AG Sponsored ADR (NASDAQ:MOLN) Short Interest Update - MarketBeat
Molecular Partners (NASDAQ:MOLN) Trading Up 3.1% – Here’s What Happened - Defense World
Molecular Partners (NASDAQ:MOLN) Trading Up 3.1%Here's What Happened - MarketBeat
Molecular Partners (NASDAQ:MOLN) Price Target Cut to $3.75 by Analysts at JPMorgan Chase & Co. - Defense World
Molecular Partners (NASDAQ:MOLN) Trading Down 2.2%What's Next? - MarketBeat
EBITDA per share of Molecular Partners AG Sponsored ADR – TRADEGATE:6ML0 - TradingView
Molecular Partners (NASDAQ:MOLN) Stock Price Down 2.1% – Here’s What Happened - Defense World
Molecular Partners AG (MOLNZ.XC) Stock Price, News, Quote & History - Yahoo
Molecular Partners (NASDAQ:MOLN) Trading 1.5% HigherHere's What Happened - MarketBeat
Liminatus Pharma (LIMN) Short Interest Ratio and Volume 2025 - MarketBeat
Molecular Partners (NASDAQ:MOLN) Price Target Cut to $4.00 by Analysts at JPMorgan Chase & Co. - MarketBeat
Leerink Partnrs Has Bullish Estimate for MOLN Q3 Earnings - MarketBeat
Why Serina Therapeutics Shares Are Trading Higher By Over 25%; Here Are 20 Stocks Moving Premarket - Benzinga
US NYSE/NASD Stock Directory - Minichart
Walmart, Deere, Applied Materials set to report earnings Thursday - Investing.com Nigeria
Here's Why Molecular Partners AG Sponsored ADR (MOLN) Could be Great Choice for a Bottom Fisher - Yahoo Finance
J.P. Morgan Keeps Their Buy Rating on Novo Nordisk (0QIU) - The Globe and Mail
Molecular Partners (MOLN) Stock Trends and Sentiment 2025 - MarketBeat
Molecular Partners (MOLN) Stock Forecast and Price Target 2026 - MarketBeat
Molecular Partners Announces All Board Proposals Approved at the Annual General Meeting By Investing.com - Investing.com South Africa
Skye Bioscience (SKYE) Short Interest & Short Float | Updated Nov 2025 - MarketBeat
symbol__ Stock Quote Price and Forecast - CNN
MIRA Pharmaceuticals (MIRA) Short Interest & Short Float | Updated Mar 2026 - MarketBeat
Stock Market News Today - Stock Titan
Stock Ratings and Recommendations: Understanding Analyst Ratings - MarketBeat
MAIA Biotechnology (MAIA) Short Interest & Short Float | Updated Dec 2025 - MarketBeat
Acrivon Therapeutics (ACRV) Short Interest & Short Float | Updated Mar 2026 - MarketBeat
What is the current Price Target and Forecast for Molecular Partners AG Sponsored ADR (MOLN) - Zacks Investment Research
Senti Biosciences (SNTI) Short Interest & Short Float | Updated Dec 2025 - MarketBeat
US stock market gainers for the last week of April 2022 - Nairametrics
Novartis and Molecular Partners report positive topline data from Phase 2 study for ensovibep (MP0420), a DARPin antiviral therapeutic for COVID-19 - Novartis
Molecular Partners (MOLN) 10K Form and SEC Filings 2025 - MarketBeat
Evaxion A/S (EVAX) Short Interest & Short Float | Updated Dec 2025 - MarketBeat
MOLNMolecular Partners AG ADR Stock Price and Quote - Finviz
Citi Appointed as Depositary Bank for Molecular Partners AG’s ADR Programme - Business Wire
Molecular Partners (MOLN) Earnings Date and Reports 2026 - MarketBeat
Molecular Partners (MOLN) Competitors and Alternatives 2025 - MarketBeat
Molecular Partners (MOLN) Stock Price, News & Analysis - MarketBeat
MOLN Stock Price and Chart — NASDAQ:MOLN - TradingView — Track All Markets
Novartis and Molecular Partners announce start of EMPATHY clinical trial for ensovibep for the treatment of COVID-19 - Novartis
Valneva SE (VALN) Stock Price, News, Quote & History - Yahoo
BioAtla (BCAB) Short Interest & Short Float | Updated Dec 2025 - MarketBeat
Novartis announces collaboration with Molecular Partners to develop two DARPin® therapies designed for potential use against COVID-19 - Novartis
bluebird bio (BLUE) Short Interest & Short Float | Updated Dec 2025 - MarketBeat
Applied Therapeutics (APLT) Short Interest & Short Float | Updated Nov 2025 - MarketBeat
PDS Biotechnology (PDSB) Short Interest & Short Float | Updated Jan 2026 - MarketBeat
BioXcel Therapeutics (BTAI) Short Interest & Short Float | Updated Dec 2025 - MarketBeat
Stock Market Alerts - MarketBeat
MLLCF News Today | Why did Molecular Partners stock go up today? - MarketBeat
RocheDoing now what patients need next - Roche
MOLN Stock Price and Chart — SIX:MOLN - TradingView — Track All Markets
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):